<http://schema.org/potentialAction>
_:b1
<http://www.genengnews.com/Login.aspx?ReturnURL=%2Fgen-news-highlights%2Favedro-acquires-riboflavin-ip-for-transepithelial-cross-linking-in-keratoconus-therapy%2F81245677%2F%3Fkwrd%3DFormulation>